During the past decade, Groupe Hospitalier Pellegrin; Service de neurochirurgie B conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Groupe Hospitalier Pellegrin; Service de neurochirurgie B" are "Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Alzheimer's Disease" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Progressive Multiple Sclerosis (PMS)" (1 trials). Many other conditions were trialed in "Groupe Hospitalier Pellegrin; Service de neurochirurgie B" in a lesser frequency.

Most popular intervention types in "Groupe Hospitalier Pellegrin; Service de neurochirurgie B" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (6 trials), "Placebo" (2 trials), "Antihistamine" (1 trials), "Fenebrutinib" (1 trials) and "Methylprednisolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Groupe Hospitalier Pellegrin; Service de neurochirurgie B" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Groupe Hospitalier Pellegrin; Service de neurochirurgie B". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Groupe Hospitalier Pellegrin; Service de neurochirurgie B, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Groupe Hospitalier Pellegrin; Service de neurochirurgie B, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".